Drug lookup
Drug reference

Bismuth subsalicylate

Antacid · Anti-ulcer agent

Also known as Kaopectate, Kao-Tin

AntacidAnti-ulcer agentATC A07BB
CDSCO approvedSchedule HATC A07BB
EXCRETION
not curated
INTERACTIONS
8 major
SEVERE in our sources
PREGNANCY
Manufacturer advises avoid unless essential—no information available.
FDA category + note
Top interactionssee all 8
  • AcetazolamideSevereDatabaseDDInter
  • BrinzolamideSevereDatabaseDDInter
  • DeferasiroxSevereDatabaseDDInter
  • DiclofenamideSevereDatabaseDDInter

Mechanism

Bismuth subsalicylate is thought to act by decreasing prostaglandin synthesis in the intestinal mucosa, thereby reducing chloride secretion. It also has weak antibacterial action, which may contribute to its prophylactic value in travellers' diarrhoea and its role in Helicobacter pylori eradication.

Indications

Helicobacter pylori eradication (in combination with other drugs)Travellers' diarrhoea (prophylactic value)In combination with antibiotics for Helicobacter pylori eradicationPrevention of ulcer recurrencePrevention and treatment of traveler's diarrheaOther forms of episodic diarrheaAcute gastroenteritisIndigestionNauseaAbdominal crampsTraveler’s diarrheaProphylaxis of traveler’s diarrhea

Dosing

Adult
For Helicobacter pylori eradication: 525 mg 4 times a day for 7 days for first- and second-line eradication therapy; 10 days for third-line eradication therapy. For travellers' diarrhoea: 60 ml oral suspension 6 hourly.

Pharmacokinetics

Excretion
99% of bismuth passes unabsorbed into feces; salicylate absorbed in stomach and small intestine

Contraindications

  • Children under 16 years (risk of Reye’s syndrome)
  • Children and young adults <20 years of age with viral illness-associated fever (risk of Reye’s syndrome)
  • History of hypersensitivity to aspirin or other salicylates
  • Blood clotting disorders
  • Gout
  • Children (warning regarding Reye's syndrome due to salicylate content)

Side effects

Common
Black faecesBlack tongueBlackening of stools (due to formation of bismuth sulfide in the colon)Dark stools (mistaken for melena)Black staining of the tonguetemporary darkening of the tongueconstipationtinnitus
Serious
  • Reye’s syndrome (in children and young adults with viral illness)
  • Salicylate poisoning (hyperventilation, tinnitus, deafness, vasodilatation, sweating)
  • Bismuth overdose (acute encephalopathy with confusion, myoclonus, tremor, dysarthria, gait disturbances, gastrointestinal disturbances, skin reactions, discolouration of mucous membranes, renal impairment)
  • Reye's syndrome (in children due to salicylate)
  • CNS side effects
  • Hearing loss
  • Tinnitus

Pregnancy & lactation

Pregnancy

Manufacturer advises avoid unless essential—no information available.

Lactation

Manufacturer advises avoid unless essential—no information available.

Drug interactions

Acetazolamide
Severe
Database

Drug interaction classified as: distribution

Source: DDInter

Brinzolamide
Severe
Database

Clinical effect not specified

Source: DDInter

Deferasirox
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Diclofenamide
Severe
Database

Clinical effect not specified

Source: DDInter

Dorzolamide
Severe
Database

Clinical effect not specified

Source: DDInter

Methazolamide
Severe
Database

Clinical effect not specified

Source: DDInter

Methotrexate
Severe
Database

Drug interaction classified as: excretion

Source: DDInter

Ramucirumab
Severe
Database

Clinical effect not specified

Source: DDInter

4 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Antacid drugs

Ask House about Bismuth subsalicylate

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, Katzung·Verified: 2026-05-10 · House clinical team